Antimicrobial susceptibility among E. faecalis and E. faecium from France,Germany, Italy,Spain and the UK (T.E.S.T. Surveillance Study, 2004-2009)

Abstract

We report on antimicrobial activity against E. faecalis and E. faecium collected in France, Germany, Italy, Spain, and the UK between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial (UK in vitro data not included due to low isolate numbers). Overall, 1·1% (n?=?23/2068) of E. faecalis and 11·5% (n?=?103/893) of E. faecium were vancomycin-resistant. High levels of minocycline-resistant E. faecalis were reported in Germany, Spain, France, and Italy (40·2–44·2%); levofloxacin resistance was high in Germany, Italy, and Spain (31·1–41·6%). Minocycline non-susceptibility increased significantly among E. faecalis in Spain and Italy (P<0·001). No tigecycline-resistant E. faecalis were reported. Among E. faecium, resistance ranged from 72·9% (France) to 93·3% (Germany) for ampicillin, from 56·1% (France) to 90·2% (Germany) for levofloxacin, and from 75·3% (Italy) to 94·7% (Germany) for penicillin. Levofloxacin non-susceptibility increased significantly among E. faecium in France and Spain (P<0·001). The lowest rates of antimicrobial resistance among E. faecium were reported for tigecycline (2/893; 0·2%) and linezolid (3/893; 0·3%).     

枯草杆菌二联活菌颗粒对厌食症患儿血清神经肽Y和肿瘤坏死因子-α水平影响及疗效

目的探讨枯草杆菌二联活菌颗粒对厌食症患儿血清神经肽Y(NPY)和肿瘤坏死因子-α(TNF-α)水平影响及疗效。方法选取2012年6月~2014年6月在浙江省嘉兴市妇幼保健院儿童厌食症患者86例,采用随机数字表将其分为观察组(43例)和对照组(43例)。两组患儿均予以纠正患儿不良饮食习惯、健胃消食药和葡萄糖酸锌等常规治疗。观察组患儿加用枯草杆菌二联活菌颗粒1.0 g/次,2次/d,温开水冲服。疗程为6周。对照组患儿除不使用枯草杆菌二联活菌颗粒外余治疗基本同观察组。观察并记录两组患儿治疗前和治疗6周后血清NPY和TNF-α水平的变化,并比较其治疗后的临床效果及药物不良反应。结果治疗6周后,两组患儿血清NPY和TNF-α水平[观察组:(45.53±7.82)pg/m L,(10.24±2.74)mmol/L;对照组:(37.39±7.53)pg/m L,(8.19±2.13)mmol/L]较治疗前[观察组:(32.17±5.18)pg/m L,(6.82±1.76)mmol/L;对照组:(32.79±4.23)pg/m L,(7.03±1.54)mmol/L]明显上升(t=2.89、3.12、2.31、2.45,P<0.05或P<0.01),且观察组上升程度较对照组更明显(t=2.19、2.24,P<0.05);同时观察组患儿临床总有效率(93.02%)较对照组(76.74%)更佳(χ2=4.44,P<0.05)。两组患儿治疗中无明显的药物不良反应发生。结论枯草杆菌二联活菌颗粒治疗儿童厌食症的效果较确切,且安全性较好,其作用机制可能与其升高血清NPY和TNF-α水平,提高患儿的食欲密切相关。     

根管预备对粪肠球菌感染根管形成细菌渗漏的影响

目的 建立粪肠球菌感染根管,以探讨离体条件下根管预备对细菌渗漏的影响.方法 将粪肠球菌接种于离体牙所制作的带模拟根尖周组织的根管内,建立320个体外模型(对照组70个,实验组250),分别进行上1/3,上2/3,全长及超长等不同长度的根管预备,于1、7、21、35、49、63 d进行PCR、SEM检测及细菌培养.结果 超长组1d检测到细菌,全长组7d检测到细菌,其余组所有检测时间点均未检测到细菌.结论 本离体实验显示,对于粪肠球菌感染根管,在根管及根管下段未受干扰的情况下,细菌不会轻易穿出根尖孔,当根管下段受到干扰后,细菌会穿出根尖孔造成细菌渗漏.     

新生儿重症监护室5例早产儿肠球菌感染的鉴定及同源性分析

目的对北京协和医院新生儿重症监护室(neonatal intensive care units,NICU)早产儿定植和感染部位、环境及益生菌中分离出的肠球菌进行菌种鉴定及同源性分析。方法收集2017年6月1—10日NICU及益生菌制剂中分离出的肠球菌共11株,用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)进行菌种鉴定,采用微量肉汤稀释法测定临床常用抗菌药物的最低抑菌浓度(MIC),用多位点序列分型(MLST)及脉冲场凝胶电泳(PFGE)进行菌株同源性分析。结果 11株菌均为粪肠球菌,对氨苄西林、万古霉素、替考拉宁、呋喃妥因、氯霉素、左氧氟沙星、利奈唑胺等抗菌药物均表现为敏感,仅1株菌对四环素和红霉素耐药。11株粪肠球菌经PFGE分为a-d 4个克隆群,MLST分型分别为ST624、ST25、ST40及ST16,PFGE与MLST分型结果一致。结论此次NICU早产儿粪肠球菌定植或感染可能与益生菌制剂的使用及物表定植的粪肠球菌相关。     

Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate-use trial

Abstract: Vancomycin‐resistant Enterococcus faecium (VRE) is increasing in incidence in solid organ transplant recipients and has a high (up to 83%) associated mortality rate. Until recently, there have been no consistently effective antimicrobial therapies for VRE infection. Linezolid is a new antibiotic that belongs to the class of oxazolidinones approved by the FDA for the treatment of VRE infections, including those with bacteremia. Here, we report the experience with linezolid in an open‐label, compassionate‐use trial at 53 US centers for the treatment of documented VRE infections in patients with solid organ transplants. Eighty‐five patients with solid organ transplants and documented VRE infections were studied. Blood cultures were positive for VRE in 43 patients, while 42 patients had other, non‐rectal, sites of infection. Fifty‐three patients responded well to treatment, with clinical resolution of the infection (62.4% survival rate). Of these, 47 had documented negative cultures post therapy. The mean duration of therapy for cured patients was 23.5 days. Thirty‐two (37.6%) patients died, 28 due to sepsis and organ failure (32.9% failure rate), and 4 due to unrelated causes. Mortality rates for patients with bacteremia were comparable to mortality rates observed with patients who had positive cultures from other sites. Adverse reactions to linezolid included thrombocytopenia (4.7%), decreased leukocyte count (3.5%), and an increase in blood pressure (1.2%), none of which led to discontinuation of therapy. Linezolid appears to be a safe and effective treatment option for VRE, even in the presence of bacteremia, and may lead to decreased mortality in solid organ transplant recipients with VRE infection.     

持续性根尖周炎中粪肠球菌临床株的分离与鉴定

目的 优化持续性根尖周炎优势菌粪肠球菌临床株的分离、培养、鉴定方法,分离获得粪肠球菌临床菌株.方法 选择30例持续性根尖周炎患者,严格无菌行根尖手术,从切除的根尖及根尖周病变组织中分离培养粪肠球菌临床株,通过形态学观察、生化鉴定及16SrRNA基因扩增测序分析特异性片段扩增方法进行鉴定,获得粪肠球菌菌株.结果 临床样本中培养出乳白色、边缘光滑、隆起的菌落、革兰氏染色阳性的球菌17例,生化检测该菌株耐低温、高温、盐、碱特性及糖代谢特点符合粪肠球菌生化特点,16SrRNA基因扩增测序,经过与NCBI数据库比对,与粪肠球菌致病菌16SrRNA基因序列相似度近99％菌株15例,特异性引物扩增可得到目标条带菌株15例.结论 从30例持续性根尖周炎中分离获得粪肠球菌临床株15株.     

Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database

PURPOSE: To describe clinical features and outcomes of enterococcal left-sided native valve endocarditis and to compare it to endocarditis caused by other pathogens. SUBJECTS AND METHODS: Patients in the International Collaboration on Endocarditis-Merged Database were included if they had left-sided native valve endocarditis. Demographic characteristics, clinical features, and outcomes were analyzed. Multivariable analysis evaluated enterococcus as a predictor of mortality. RESULTS: Of 1285 patients with left-sided native valve endocarditis, 107 had enterococcal endocarditis. Enterococcal endocarditis was most frequently seen in elderly men, frequently involved the aortic valve, tended to produce heart failure rather than embolic events, and had relatively low short-term mortality. Compared to patients with non-enterococcal endocarditis, patients with enterococcal endocarditis had similar rates of nosocomial acquisition, heart failure, embolization, surgery, and mortality. Compared to patients with streptococcal endocarditis, patients with enterococcal endocarditis were more likely to be nosocomially acquired (9 of 59 [15%] vs 2 of 400 [1%]; P <.0001) and have heart failure (49 of 107 [46%] vs 234 of 666 [35%]; P = 0.03). Compared to patients with S. aureus endocarditis, patients with enterococcal endocarditis were less likely to embolize (28 of 107 [26%] vs 155 of 314 [49%]; P <.0001) and less likely to die (12 of 107 [11%] vs 83 of 313 [27%]; P = 0.001). Multivariable analysis of all patients with left-sided native valve endocarditis showed that enterococcal endocarditis was associated with lower mortality (odds ratio [OR] 0.49; 95% confidence interval [CI] 0.24 to 0.97). CONCLUSIONS: Enterococcal native valve endocarditis has a distinctive clinical picture with a good prognosis.